Related Experiment Video
Updated: Jun 16, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Primary and salvage cryotherapy for prostate cancer
David S Finley1, Frederic Pouliot, David C Miller
1Department of Urology, Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, 924 Westwood Boulevard, Suite 1050, Box 957207, Los Angeles, CA 90095-7207, USA. dfinley@mednet.ucla.edu
The Urologic Clinics of North America
|February 16, 2010
Summary
Cryotherapy uses extreme cold to destroy tissue. Prostate cryoablation is now an established treatment for localized prostate cancer, with potential for focal ablation in select cases.
Area of Science:
- Urology
- Oncology
- Medical Technology
Background:
- Cryotherapy is a validated method for tissue ablation using localized extreme cold.
- The American Urological Association acknowledges prostate cryoablation as a standard treatment for specific prostate cancer scenarios.
- Recent research indicates potential applications for focal prostate cryoablation.
Purpose of the Study:
- To review the current advancements and applications of prostate cryoablation.
- To discuss the established and emerging roles of cryotherapy in managing prostate cancer.
Main Methods:
- Literature review of current state-of-the-art cryoablation techniques.
- Analysis of data regarding prostate cryoablation efficacy and indications.
Main Results:
- Prostate cryoablation is recognized as an established treatment for newly diagnosed and recurrent organ-confined prostate cancer.
- Evidence suggests cryoablation may be suitable for focal ablation in specific patient profiles.
Conclusions:
- Cryoablation is a significant therapeutic option in the urological management of prostate cancer.
- The role of cryotherapy in focal prostate cancer treatment warrants further investigation and highlights its evolving applications.
